Skip to main content

Beyond Transplantation: Urinary Infectious Complications and Malignancy Risk in Autosomal Dominant Polycystic Kidney Disease

  • Chapter
  • First Online:
Complications in Kidney Transplantation
  • 350 Accesses

Abstract

Polycystic kidney disease is the most common genetic kidney disorder; the autosomal dominant form accounts for 10% of cases of end-stage kidney disease (ESKD). Kidney transplantation offers patients with ESKD the ability to recover their kidney function and alleviate symptoms associated with advanced kidney disease. However, the structural abnormalities associated with multi-organ cystic formations and vascular malformations are complications that persist post-transplant and must be periodically monitored.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet. 2007;369(9569):1287–301. ISSN 0140-6736

    Article  PubMed  Google Scholar 

  2. Goldman JD, Julian K. Urinary tract infections in solid organ transplant recipients: guidelines from the American Society of Transplantation infectious diseases Community of Practice. Clin Transpl. 2019;33(9):e13507.

    Article  Google Scholar 

  3. Alangaden G. Urinary tract infections in renal transplant recipients. Curr Infect Dis Rep. 2007;9:475–9.

    Article  PubMed  Google Scholar 

  4. Ariza-Heredia EJ, Beam EN, Lesnick TG, Kremers WK, Cosio FG, Razonable RR. Urinary tract infections in kidney transplant recipients: role of gender, urologic abnormalities, and antimicrobial prophylaxis. Ann Transplant. 2013;18:195–204.

    Article  PubMed  Google Scholar 

  5. Velioglu A, Guneri G, Arikan H, Asicioglu E, Tigen ET, et al. Incidence and risk factors for urinary tract infections in the first year after renal transplantation. PLoS One. 2021;16(5):e0251036.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Michail A, Dimitrios N, Eleftherios M. Urinary tract infections caused by ESBL-producing Enterobacteriaceae in renal transplant recipients: a systematic review and meta-analysis. Transpl Infect Dis. 2017;19(6)

    Google Scholar 

  7. Stiasny B, Ziebell D, Graf S, Hauser IA, Schulze BD. Clinical aspects of renal transplantation in polycystic kidney disease. Clin Nephrol. 2002;58(1):16–24.

    Article  PubMed  Google Scholar 

  8. Jacquet A, Pallet N, Kessler M, Hourmant M, Garrigue V, Rostaing L, Kreis H, Legendre C, Mamzer-Bruneel MF. Outcomes of renal transplantation in patients with autosomal dominant polycystic kidney disease: a nationwide longitudinal study. Transpl Int. 2011;24(6):582–7.

    Article  PubMed  Google Scholar 

  9. Rozanski J, Kozlowska I, Myslak M, Domanski L, Sienko J, Ciechanowski K, Ostrowski M. Pretransplant nephrectomy in patients with autosomal dominant polycystic kidney disease. Transplantation Proceedings. 2005;37(2) ISSN 0041-1345

    Google Scholar 

  10. Patel P, Horsfield C, Compton F, Taylor J, Koffman G, Olsburgh J. Native nephrectomy in transplant patients with autosomal dominant polycystic kidney disease. Ann R Coll Surg Engl. 2011;93(5):391–5.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Yu TM, Chuang YW, Yu MC, Chen CH, Yang CK, Huang ST, Lin CL, Shu KH, Kao CH. Risk of cancer in patients with polycystic kidney disease: a propensity-score matched analysis of a nationwide, population-based cohort study. Lancet Oncol. 2016;17(10):1419–25. https://doi.org/10.1016/S1470-2045(16)30250-9. Epub 2016 Aug 20

    Article  PubMed  Google Scholar 

  12. Chewcharat A, Thongprayoon C, Bathini T, et al. Incidence and mortality of renal cell carcinoma after kidney transplantation: a meta-analysis. J Clin Med. 2019;8(4):530. https://doi.org/10.3390/jcm8040530. Published 2019 Apr 17

    Article  PubMed Central  Google Scholar 

  13. Hajj P, Ferlicot S, Massoud W, Awad A, Hammoudi Y, Charpentier B, Durrbach A, Droupy S, Benoît G. Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and chronic renal failure. Urology. 2009;74(3):631–4. https://doi.org/10.1016/j.urology.2009.02.078. Epub 2009 Jul 18. PMID: 19616833

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank Dr. Alexander Gallan for providing the slides illustrating the nephrectomy histopathology and summarizing the findings.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Emily Joachim .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Hindi, J., Joachim, E. (2022). Beyond Transplantation: Urinary Infectious Complications and Malignancy Risk in Autosomal Dominant Polycystic Kidney Disease. In: Aziz, F., Parajuli, S. (eds) Complications in Kidney Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-031-13569-9_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-13569-9_31

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-13568-2

  • Online ISBN: 978-3-031-13569-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics